Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Vanderbilt Epidemiology PhD Program, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
BMJ Open. 2023 Apr 21;13(4):e067878. doi: 10.1136/bmjopen-2022-067878.
To systematically review and evaluate diagnostic models used to predict viral acute respiratory infections (ARIs) in children.
Systematic review.
PubMed and Embase were searched from 1 January 1975 to 3 February 2022.
We included diagnostic models predicting viral ARIs in children (<18 years) who sought medical attention from a healthcare setting and were written in English. Prediction model studies specific to SARS-CoV-2, COVID-19 or multisystem inflammatory syndrome in children were excluded.
Study screening, data extraction and quality assessment were performed by two independent reviewers. Study characteristics, including population, methods and results, were extracted and evaluated for bias and applicability using the Checklist for Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies and PROBAST (Prediction model Risk Of Bias Assessment Tool).
Of 7049 unique studies screened, 196 underwent full text review and 18 were included. The most common outcome was viral-specific influenza (n=7; 58%). Internal validation was performed in 8 studies (44%), 10 studies (56%) reported discrimination measures, 4 studies (22%) reported calibration measures and none performed external validation. According to PROBAST, a high risk of bias was identified in the analytic aspects in all studies. However, the existing studies had minimal bias concerns related to the study populations, inclusion and modelling of predictors, and outcome ascertainment.
Diagnostic prediction can aid clinicians in aetiological diagnoses of viral ARIs. External validation should be performed on rigorously internally validated models with populations intended for model application.
CRD42022308917.
系统评价和评估用于预测儿童病毒性急性呼吸道感染(ARI)的诊断模型。
系统评价。
从 1975 年 1 月 1 日至 2022 年 2 月 3 日,检索了 PubMed 和 Embase。
纳入了预测儿童(<18 岁)因病毒性 ARI 到医疗机构就诊的诊断模型研究,研究语言为英文。排除了针对 SARS-CoV-2、COVID-19 或儿童多系统炎症综合征的预测模型研究。
由两名独立的综述作者进行研究筛选、数据提取和质量评估。使用预测模型研究的关键评估清单和 PROBAST(预测模型风险偏倚评估工具)提取并评估研究特征,包括人群、方法和结果,以评估偏倚和适用性。
从 7049 篇独特的研究中筛选出 196 篇进行全文审查,最终纳入 18 篇研究。最常见的结局是病毒特异性流感(n=7;58%)。8 项研究(44%)进行了内部验证,10 项研究(56%)报告了区分度测量值,4 项研究(22%)报告了校准度测量值,均未进行外部验证。根据 PROBAST,所有研究在分析方面均存在高偏倚风险。然而,现有研究在研究人群、预测因素的纳入和建模以及结局确定方面,存在的偏倚问题较少。
诊断预测可以帮助临床医生对病毒性 ARI 的病因做出诊断。应在具有预期模型应用人群的严格内部验证模型上进行外部验证。
PROSPERO 注册号:CRD42022308917。